BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30695070)

  • 1. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
    Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
    PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
    Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatics analysis of the clinicopathological and prognostic significance of
    Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
    J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells.
    Zhang J; Qian L; Wu J; Lu D; Yuan H; Li W; Ying X; Hu S
    Biochem Biophys Res Commun; 2019 May; 513(2):472-478. PubMed ID: 30979502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HN1 as a diagnostic and prognostic biomarker for liver cancer.
    Liu Z; Yang D; Li Y; Jiao Y; Lv G
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.
    Fu Z; Jiao Y; Li Y; Ji B; Jia B; Liu B
    Medicine (Baltimore); 2019 Dec; 98(51):e18487. PubMed ID: 31861032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
    Xing J; Tian Y; Ji W; Wang X
    Medicine (Baltimore); 2020 Feb; 99(9):e19230. PubMed ID: 32118724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
    Li Y; Jiao Y; Li Y; Liu Y
    Dis Markers; 2019; 2019():1569049. PubMed ID: 31772683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
    Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
    Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z
    Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a 7-miRNA-Based Risk Score System for Predicting Prognosis of Pancreatic Cancer.
    Zhuang H; Ma Z; Huang K; Zhou Z; Huang B; Sun Z; Hou B; Zhang C
    Pancreas; 2020; 49(5):655-662. PubMed ID: 32433403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.